Ofir Livne, MD, MPH

Ofir Livne is an Assistant Professor of Clinical Psychiatry at Columbia University and a Research Scientist in the Division of Translational Epidemiology at the New York State Psychiatric Institute. His research focuses on psychiatric and substance use epidemiology across the lifecourse, and includes studies on the risks, social determinants, clinical correlates, and mental health outcomes of substance use, primarily cannabis use. His studies rely on data from large-scale national surveys, electronic health records (EHR), clinical samples, and online samples recruited via social media platforms.

Dr. Livne’s research is funded by the U.S. National Institutes of Health. He is currently Principal Investigator on a K23 Career Development Award from the National Institute on Drug Abuse (NIDA) to assess cannabis use patterns and associations with cognitive impairment in older adults. He is interested in investigating the intersection of substance use, psychiatric disorders, and the aging population.

Dr. Livne is an adult psychiatrist. He earned his MD from Tel-Aviv University in Israel, and completed his clinical training and residency at Tel-Aviv Sourasky Medical Center in Israel and in Montefiore Medical Center (Albert Einstein College of Medicine) in New-York. He completed an MPH in epidemiology at the T.H. Chan School of Public Health, Harvard University, and a NIDA-funded T32 postdoctoral research fellowship in the Substance Abuse Epidemiology Training Program within the Department of Epidemiology at the Mailman School of Public Health, Columbia University.